Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

NCT01652872 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

756

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia in Chronic Kidney Disease Patients Not on Dialysis

Interventions

BIOLOGICAL: Darbepoetin alfa
OTHER: Placebo

Sponsor

Amgen